Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Control Bionics Ltd. ( (AU:CBL) ) has shared an announcement.
Control Bionics Ltd. has announced the quotation of 8,852,473 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of September 17, 2025. This move is part of a previously announced transaction, potentially enhancing the company’s market presence and providing additional capital to support its operations and growth strategies.
More about Control Bionics Ltd.
Control Bionics Ltd. operates in the biotechnology industry, focusing on developing and providing assistive technology solutions. The company specializes in creating products that enable individuals with disabilities to communicate and interact with their environment, emphasizing market segments that require advanced communication aids.
Average Trading Volume: 137,709
Technical Sentiment Signal: Sell
Current Market Cap: A$12.02M
For an in-depth examination of CBL stock, go to TipRanks’ Overview page.